|
Re: Also interesting, but less encouraging
|
11
|
Resverlogix Corp.
|
Aug 04, 2022 02:45PM
|
|
Even DM must take PCR tests (at least up to Feb 28)
|
9
|
Resverlogix Corp.
|
Mar 02, 2022 05:25PM
|
|
Article in National Post Feb 11
|
11
|
Resverlogix Corp.
|
Feb 12, 2022 09:38AM
|
|
Don on CTV Calgary News 6:18pm
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 08:24PM
|
|
FDA halts use of antibody drugs that don't work vs. omicron
|
6
|
Resverlogix Corp.
|
Jan 24, 2022 06:41PM
|
|
Edmonton Journal Article
|
10
|
Resverlogix Corp.
|
Jan 18, 2022 07:49PM
|
|
Re: Trial started
|
7
|
Resverlogix Corp.
|
Jan 18, 2022 08:13AM
|
|
Re: Update on the 16th
|
2
|
Resverlogix Corp.
|
Dec 18, 2021 03:24PM
|
|
Resverlogix: The Future of Drug Development, CEO Clip Video
|
|
Resverlogix Corp.
|
Dec 16, 2021 03:42PM
|
|
BET Inhibitors may help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
|
5
|
Zenith Epigenetics
|
Jun 22, 2021 09:34AM
|
|
Overcoming a newly recognized form of resistance to modern prostate cancer drugs
|
8
|
Zenith Epigenetics
|
Jun 20, 2021 09:39AM
|
|
Anne McCaffrey passing
|
17
|
Resverlogix Corp.
|
Jun 04, 2021 11:51AM
|
|
Re: COVID trial now in CTD
|
3
|
Resverlogix Corp.
|
May 15, 2021 01:00PM
|
|
COVID trial now in CTD
|
10
|
Resverlogix Corp.
|
May 15, 2021 11:51AM
|
|
Inventory and Revenue calcs
|
9
|
Resverlogix Corp.
|
May 13, 2021 11:01AM
|
|
Institutional Investors
|
1
|
Resverlogix Corp.
|
Dec 11, 2020 07:02PM
|
|
Some additional COVID 19 gene targets
|
3
|
Resverlogix Corp.
|
Dec 11, 2020 06:15PM
|
|
Re: By Christmas time.....
|
10
|
Resverlogix Corp.
|
Dec 09, 2020 04:15PM
|
|
Apabetalone and Potential COVID-19 Effectiveness
|
12
|
Resverlogix Corp.
|
Oct 26, 2020 09:01AM
|
|
Re: Rules of thumb and broken thumbs...
|
3
|
Resverlogix Corp.
|
Sep 29, 2020 04:05PM
|
